We are live on ! Find out more
AI

AXS Investments Portfolio holdings

AUM $248M
1-Year Est. Return 15.95%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+15.95%
3 Year Est. Return
+69.63%
5 Year Est. Return
+60.73%
10 Year Est. Return
AUM
$417M
AUM Growth
-$337K
Cap. Flow
-$30.2M
Cap. Flow %
-7.24%
Top 10 Hldgs %
18.44%
Holding
439
New
47
Increased
101
Reduced
132
Closed
152

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.67M
2
HUBB icon
Hubbell
HUBB
+$1.54M
3
HUBS icon
HubSpot
HUBS
+$1.51M
4
MSFT icon
Microsoft
MSFT
+$1.31M
5
CAG icon
Conagra Brands
CAG
+$1.26M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.9M
2
META icon
Meta Platforms (Facebook)
META
+$1.67M
3
CPAY icon
Corpay
CPAY
+$1.47M
4
KKR icon
KKR & Co
KKR
+$1.36M
5
CNC icon
Centene
CNC
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 30.71%
2 Real Estate 16.49%
3 Financials 11.24%
4 Communication Services 8.32%
5 Healthcare 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTS icon
276
Watts Water Technologies
WTS
$13.1B
$211K 0.05%
+995
New +$202K
COLL icon
277
Collegium Pharmaceutical
COLL
$956M
$211K 0.05%
+5,445
New +$191K
MTX icon
278
Minerals Technologies
MTX
$2.34B
$211K 0.05%
+2,805
New +$197K
XHE icon
279
State Street SPDR S&P Health Care Equipment ETF
XHE
$163M
$209K 0.05%
2,375
-265
-10% -$22.5K
SXC icon
280
SunCoke Energy
SXC
$797M
$209K 0.05%
+18,530
New +$200K
LNW
281
DELISTED
Light & Wonder
LNW
$209K 0.05%
2,045
-7,455
-78% -$673K
MS icon
282
Morgan Stanley
MS
$340B
$208K 0.05%
2,211
+143
+7% +$12.6K
VRTS icon
283
Virtus Investment Partners
VRTS
$1.1B
$205K 0.05%
+825
New +$195K
HYT icon
284
BlackRock Corporate High Yield Fund
HYT
$1.37B
$196K 0.05%
+20,000
New +$193K
JPC icon
285
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$144K 0.03%
20,000
-7,000
-26% -$49.7K
A icon
286
Agilent Technologies
A
$41.2B
-845
Closed -$117K
AAT
287
American Assets Trust
AAT
$1.4B
-20,747
Closed -$467K
ABG icon
288
Asbury Automotive
ABG
$3.85B
-170
Closed -$38.2K
ACB
289
Aurora Cannabis
ACB
$185M
-113,538
Closed -$541K
ACGL icon
290
Arch Capital
ACGL
$33.6B
-1,300
Closed -$96.6K
AFCG
291
AFC Gamma
AFCG
$63.4M
-122,538
Closed -$1.01M
RYM
292
RYTHM Inc
RYM
$49M
-3,201
Closed -$57.6K
ALV icon
293
Autoliv
ALV
$9B
-6,000
Closed -$661K
AMAT icon
294
Applied Materials
AMAT
$428B
-504
Closed -$81.7K
AMD icon
295
PUT
Advanced Micro Devices
AMD
$789B
-150
Closed -$115K
AMPH icon
296
Amphastar Pharmaceuticals
AMPH
$916M
-8,000
Closed -$495K
AMZN icon
297
PUT
Amazon
AMZN
$2.96T
-150
Closed -$50.1K
AN icon
298
AutoNation
AN
$6.92B
-500
Closed -$75.1K
ANET icon
299
PUT
Arista Networks
ANET
$238B
-280
Closed -$30.1K
ANSS
300
DELISTED
Ansys
ANSS
-1,792
Closed -$650K

Similar funds

AXS Investments's Q1 2024 Portfolio in Review

As of Q1 2024, AXS Investments held 439 positions worth $417M, down 0.08% from $417M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

AXS Investments withdrew a net $30.2M in Q1 2024, closing 152 positions and reducing 132 holdings. Its most notable exit was Corpay, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AXS Investments opened a new position in State Street SPDR S&P Biotech ETF worth $1.71M.

  • AXS Investments's largest Q1 2024 buy was State Street SPDR S&P Biotech ETF: 18,000 shares worth $1.71M.
  • AXS Investments added most to Microsoft in Q1 2024, an estimated $1.31M increase.
  • AXS Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.9M.
  • AXS Investments fully exited Corpay in Q1 2024, selling an estimated $1.47M.
  • AXS Investments's ten largest holdings make up 18% of its $417M portfolio in Q1 2024.
  • AXS Investments opened 47 new positions and closed 152 in Q1 2024.
  • AXS Investments's portfolio value fell 0.08% quarter-over-quarter to $417M.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.